Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles

References

• Johnson RE, Strain EC, Amass L. (2003). Buprenorphine: how to use it right. Drug Alcohol Depend 70:S59–77
   PubMed Web of Science ®Google Scholar
• Fudala PJ, Yu E, Macfadden W, et al. (1998). Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts. Drug Alcohol Depend 50:1–8
   PubMed Web of Science ®Google Scholar
• Liu CH, Liu H, Han XY, et al. (2005). Synthesis and characterization of thienorphine and its glucuronide conjugate. Synth Commun 35:701–10
   Web of Science ®Google Scholar
• De Jong WH, Borm PJ. (2008). Drug delivery and nanoparicles: applications and hazards. Int J Nanomed 3:133–49
   PubMed Web of Science ®Google Scholar
• Hulse GK, Stalenberg V, McCallum D, et al. (2005). Histological changes over time around the site of sustained release naltrexone-poly(dl-lactide) implants in humans. J Control Release 108:43–55
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. (2011). Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42:445–51
   PubMed Web of Science ®Google Scholar
• Shi K, Cui F, Yamamoto H, Kawashima Y. (2009). Optimized formulation of high-payload PLGA nanoparicles containing insulin-lauryl sulfate complex. Drug Dev Ind Pharm 35:177–84
   PubMed Web of Science ®Google Scholar
• He B, Lin P, Jia ZR, et al. (2013). The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials 34:6082–98
   PubMed Web of Science ®Google Scholar
• Thirawong N, Nunthanid J, Puttipipatkhachorn Satit, et al. (2007). Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer. Eur J Pharm Biopharm 67:132–40
   PubMed Web of Science ®Google Scholar
• He B, Jia ZR, Du WW, et al. (2013). The transport pathways of polymer nanoparticles in MDCK epithelial cells. Biomaterials 34:4309–26
   PubMed Web of Science ®Google Scholar
• Merwe SM, Verhoef JC, Kotzé AF, et al. (2004). N-Trimethyl chitosan chloride as absorption ehancer in oral peptide drug delivery development and characterization of minitablet and granule formulations. Eur J Pharm Biopharm 57:85–91
   PubMed Web of Science ®Google Scholar
• Guo XH, Zhang XX, Ye L, et al. (2014). Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol. J Drug Target published online:1–7
   Google Scholar
• Zhang XY, Sun MZ, Zheng AP, et al. (2012). Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Sci 45:632–8
   PubMed Web of Science ®Google Scholar
• Perez C, Sanchez A, Putnam D, et al. (2001). Poly (lactic acid)-poly (ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release 75:211–24
   PubMed Web of Science ®Google Scholar
• Garinot M, Fievez V, Pourcelle V, et al. (2007). PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 120:195–204
   PubMed Web of Science ®Google Scholar
• Viholal H, Laukkanen A, Valtola L, et al. (2005). Cytotoxicity of thermosensitive polymers poly (N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam). Biomaterials 26:3055–64
   PubMed Web of Science ®Google Scholar
• Chung YL, Kim JC, Kim YH, et al. (2010). The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated pluronic on tumor targeting. J Control Release 143:374–82
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH) harmonized tripartite guideline. (2005). Impurities: guideline for residual solvents, Q3C (R3). In International Conference on Harmonisation harmonised tripartite guideline Current Step 4 version. Available at:http://www.ich.org/LOB/media/MEDIA423.pdf
   Google Scholar
• Nahar M, Mishra D, Dubey V, et al. (2008). Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed Nanotech Bio Med 4:252–62
   PubMed Web of Science ®Google Scholar
• Jain AK, Swarnakar NK, Godugu C, et al. (2011). The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32:503–15
   PubMed Web of Science ®Google Scholar
• Jayakumar R, Chennazhi KP, Muzzarelli RAA, et al. (2010). Chitosan conjugated DNA nanoparticles in gene therapy. Carbohyd Polym 79:1–8
   Web of Science ®Google Scholar